SCHEMBL17677243

SCHEMBL17677243

NN1CC=C(c2ccccn2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.50
DRD4 P21917 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 3/20 0.43
NPC1 O15118 1/20 0.43
TSHR P16473 1/20 0.43
KDM4E B2RXH2 3/20 0.42
LMNA P02545 2/20 0.42
CCR1 P32246 2/20 0.42
CCR5 P51681 2/20 0.42
CCR8 P51685 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
METAP1 P53582 1/20 0.42
BLM P54132 1/20 0.42
HIF1A Q16665 1/20 0.42
DOHH Q9BU89 1/20 0.42
P4HTM Q9NXG6 1/20 0.42
ALDH1A1 P00352 1/20 0.40
AOC3 Q16853 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8488039 0.80 SIGMAR1 (0.53) SIGMAR1DRD4KDM4ELMNAPOLB
SCHEMBL25124555 0.76 SIGMAR1 (0.60) SIGMAR1DRD4SMN1; SMN2KDM4ELMNA
SCHEMBL31754615 0.76 DRD4 (0.48) SIGMAR1DRD4SMN1; SMN2KDM4ELMNA
SCHEMBL7476654 0.76 SIGMAR1 (0.44) SIGMAR1DRD4SMN1; SMN2TP53NPC1
SCHEMBL30097493 0.75 ALDH1A1 (0.59) SIGMAR1DRD4SMN1; SMN2NPC1TSHR
SCHEMBL12100560 0.75 ALDH1A1 (0.59) SIGMAR1DRD4SMN1; SMN2NPC1TSHR
SCHEMBL9080596 0.74 ALDH1A1 (0.50) SIGMAR1DRD4SMN1; SMN2NPC1TSHR
SCHEMBL18382209 0.74 DRD4 (0.46) SIGMAR1DRD4SMN1; SMN2TP53NPC1
SCHEMBL14890550 0.74 TDO2 (0.51) SIGMAR1DRD4ALDH1A1
SCHEMBL6969008 0.74 DRD4 (0.61) SIGMAR1DRD4SMN1; SMN2HIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3006438-A1 CYCLIC AMINOMETHYL PYRIMIDINE DERIVATIVE Sumitomo Dainippon Pharma Co., Ltd. (JP) 2016-04-13 EP disclosed